OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy
Qiaohong Geng, Peifu Jiao
Molecules (2024) Vol. 29, Iss. 2, pp. 454-454
Open Access | Times Cited: 8
Qiaohong Geng, Peifu Jiao
Molecules (2024) Vol. 29, Iss. 2, pp. 454-454
Open Access | Times Cited: 8
Showing 8 citing articles:
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 57
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 57
A mechanistic, functional, and clinical perspective on targeting CD70 in cancer
Sandeep Kumar, Sowdhamini Mahendiran, Rakesh Sathish Nair, et al.
Cancer Letters (2024) Vol. 611, pp. 217428-217428
Open Access | Times Cited: 5
Sandeep Kumar, Sowdhamini Mahendiran, Rakesh Sathish Nair, et al.
Cancer Letters (2024) Vol. 611, pp. 217428-217428
Open Access | Times Cited: 5
Blood cancer therapy with synthetic receptors and CRISPR technology
Haiying Zhang, Mingxin Zhong, Jingdong Zhang, et al.
Leukemia Research (2025) Vol. 150, pp. 107646-107646
Closed Access
Haiying Zhang, Mingxin Zhong, Jingdong Zhang, et al.
Leukemia Research (2025) Vol. 150, pp. 107646-107646
Closed Access
Modulation of N-glycosylation in the PD-1: PD-L1 axis as a strategy to enhance cancer immunotherapies
Monika Granica, Gustaw Laskowski, Paweł Link-Lenczowski, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189274-189274
Open Access
Monika Granica, Gustaw Laskowski, Paweł Link-Lenczowski, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189274-189274
Open Access
Small molecules targeting immune checkpoint proteins for cancer immunotherapy: a patent and literature review (2020-2024)
Qiaohong Geng, Juanjuan Xu, Cheng Du, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Qiaohong Geng, Juanjuan Xu, Cheng Du, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access
Bispecific Antibodies in Hematologic and Solid Tumors: Current Landscape and Therapeutic Advances
Lorenzo Guidi, Julian Etessami, Carmine Valenza, et al.
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 3
Closed Access
Lorenzo Guidi, Julian Etessami, Carmine Valenza, et al.
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 3
Closed Access
Comparison of Pharmacokinetic Parameters and Biodistribution of Full-Size Antibodies and Nanoantibodies Specific to Human PD-L1
Н. А. Верлов, O. Shashkova, I. Yu. Krutetskaya, et al.
Nanobiotechnology Reports (2024) Vol. 19, Iss. S1, pp. S210-S217
Closed Access
Н. А. Верлов, O. Shashkova, I. Yu. Krutetskaya, et al.
Nanobiotechnology Reports (2024) Vol. 19, Iss. S1, pp. S210-S217
Closed Access
